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Abstract The use of nitrofuran veterinary drugs as anti-
bacterial compounds in food-producing animals has been
banned in the EU since 1995. As nitrofurans are extensive
and rapidly metabolized, control of their illegal use in animal
production must be done in edible tissues by LC-MS/MS
analysis in order to determine persistent tissue-bound
metabolites. The introduction during 2002 of the multi-
residue detection of nitrofuran tissue-bound metabolites by
LC-MS/MS for nitrofuran control in Portuguese Residues
Monitoring Plan, revealed the presence of 5-morpholinom-
ethyl-3-amino-2-oxozolidinone (AMOZ), the bound residue
of furaltadone, in a large number of samples, namely in meat
poultry samples. From the 226 analysed samples in the last
4 months of 2002, 78 were non-compliant due to the pres-
ence of AMOZ (61 broilers, 11 turkeys, 5 quails and 1 pig). In
this context, the aim of this paper is to describe the analytical
data obtained on meat samples collected from various animal
species under official Portuguese control for nitrofuran drug
residues during the so-called ‘‘Portuguese nitrofuran crisis’’.
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Introduction
The 5-nitrofurans, generally designated as nitrofurans, are
synthetic chemotherapeutic agents with a broad antimi-
crobial spectrum; they are active against gram-positive
(such as Staphylococcus, Streptococcus, Clostridium, and
several Corynebacterium), gram-negative bacteria (such as
Escherichia coli, Salmonella, Vibrio cholerae, Shigella,
and Klebsiella), and some protozoans (such as Giardia,
Histomonas meleagridis, Isopspora belli, Ballantidium
coli, or Entamoeba histolytica). Their primary action is
bacteriostatic, but at high doses they are also bactericidal
[1–3].
Furazolidone, furaltadone, nitrofurazone and nitrofur-
antoin are the most important drugs in this group of
compounds. They were used worldwide for five decades to
control bacteria and protozoa, in massive treatments of
swine and poultry, for morbidity and mortality reduction as
a result of severe gastrointestinal and respiratory infections
and in non-specific therapy of piglet enteritis necrosis. The
great popularity of nitrofurans in intensive animal farm
production was related to their low cost, generic avail-
ability, and great efficacy in the treatment of resistant
infections.
Nitrofurans’ carcinogenicity and mutagenicity has been
widely investigated, particularly, in the case of furazoli-
done. Several studies concluded that the lateral side-chain,
3-amino-2-oxazolidinone (AOZ) is responsible for the
inhibition of monoamine-oxidase (MAO) in rats after the
administration of furazolidone; and that this compound’s
degradation by hydrolysis might produce b-hydrox-
yethylhydrazine, a compound with known mutagenic and
carcinogenic properties [4]. The cytotoxicity and muta-
bility from nitrofurans were also observed in mammal’s
cells [5].
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Because of the doubts about the safety of nitrofurans and
their residues in human health, in 1993 the European Union
(EU) forbade the use of furaltadone, nitrofurantoin, and
nitrofurazone in food production animals [6]. The provi-
sional MRL for furazolidone was prolonged until 1995, and
since the manufacturers could not provided further infor-
mation about the safety of this compound and their bound
metabolites, furazolidone was included in the Annex IV of
the Council’s Regulation (EEC) 2377/90 [7]. As a conse-
quence, after January 1997 the nitrofurans were no longer
allowed in the EU as veterinary drugs.
Studies concerning the detection of nitrofurans in food
animals namely in swine and poultry have shown a rapid
depletion of parent compounds in tissues, particularly,
muscle, liver, and kidney due to their short in vivo half-life.
Nitrofuran parent compounds were only sporadically
detectable a few hours after cessation of the administration
[2, 8, 9]. In vitro, the half-life of degradation process after
the animals slaughter is different from tissue to tissue, but
equally short. As a result, the possibility of detecting the
parent administered drug within 24 h of the slaughter for
control purposes is a remote possibility [10].
Nitrofuran’s intense metabolism is responsible for the
fast disappearance of parent compounds and the formation
and accumulation of the respective biodegradation prod-
ucts. Studies carried out with radiolabelled furazolidone
showed that part of the administered compound could not
be extracted from tissues where it was bonded [8].
Subsequent studies have shown that furazolidone biodeg-
radation results in the formation of reactive intermediates
capable of binding to proteins and at least 70% of these
bound metabolites contained AOZ [11, 12]. It was also
possible to observe identical metabolic profiles for the
other most important nitrofuran drugs: 5-metilmorpholino-
3-amino-2-oxazolidone (AMOZ), 1-amino-hydantoin (AHD),
and semicarbazide (SEM), marker residues of furaltadone,
nitrofurantoin, and nitrofurazone, respectively (Fig. 1).
In order to detect the presence of nitrofurans in bio-
logical samples from food animals, many sensitive and
specific methods have been described, namely detection
and quantification of furazolidone by LC-MS in porcine
muscle [13], determination of furazolidone metabolite
(AOZ) in liver, kidney and muscle from pigs by high
performance liquid chromatography (HPLC) with ultra
violet-diode array (UV-DAD) detection [12] or with ther-
mospray LC-MS [14], analysis of furazolidone and
furaltadone metabolites in pig liver by HPLC with UV
detection and LC-MS [15] and determination of nitrofuran
metabolites in animal tissues by liquid chromatography-
tandem mass spectrometry LC-MS/MS [16]. The high
specificity and sensitivity demonstrated by LC-MS/MS for
analysis of nitrofuran metabolites and the generalization of
the use of this kind of equipment by residue laboratories
around the world, has made possible to have an effective
analytical procedure to control the long-term detection of
illicit use of these compounds with detection levels ranging
from 0.1 to 0.6 lg/kg [17].
The introduction of the method developed by RIKILT
Wageningen and DARD Belfast as part of the Food-
BRAND project into the laboratory routine for nitrofurans
detection under the Portuguese Residues Monitoring Plan
(PRMP), has exposed a previously unknown problem for
the national authorities. This paper describes obtained
analytical data on meat samples collected from various
animal species under official Portuguese control for nitro-
furan drug residues during 2002 and 2003, as well as the
implemented follow-up measures.
Experimental
Reagents and materials
All reagents and solvents were of analytical grade or better
unless stated otherwise. Methanol, hydrochloric acid, tri-
sodium phosphate dodecahydrate, sodium hydroxide, ethyl
acetate, acetic acid, and acetonitrile were supplied by
Merck (Darmstadt, Germany). Ortho-nitrobenzaldehyde
(o-NBA) was supplied by Sigma (Madrid, Spain). Water
was demineralised using a Millipore purification system
(Bedford, MA, USA).
Standards of 3-amino-2-oxazolidinone (AOZ), 5-meth-
ylmorfolino-3-amino-2-oxazolidinone (AMOZ), 1-amino-
hydantoin hydrochloride (AHD), 3-amino-2-oxazolidi-
none-fourth deuterated hydrochloride (AOZ-d4), and
5-methylmorfolino-3-amino-2-oxazolidinone-fith deuter-
ated (AMOZ- d5) were supplied by VSD of Belfast
(Veterinary Sciences Division, DARD, UK). The semi-
carbazide hydrochloride (SEM) was supplied by Sigma
(Poole, Dorset, UK).
A Moulinex mincer (Lisbon, Portugal), a Mettler Toledo
PC2000 and AE100 balances (Greifensee, Switzerland), a
Memmert incubator (Buchenbach, Germany), a Heidolph
Reax 2 overhead mixer (Schwabach, Germany), a Heraeus
Megafuge 1.0 centrifuge (Hanau, Germany), a Turbovap
Zymark evaporator (Hopkinton, MA, USA), and Whatman
PVDF filters (0.45 lm) Mini-Uniprep (Clifton, NJ, USA)
were used to perform extraction and purification procedures.
The LC system (Agilent Technologies, Palo Alto, CA,
USA) consisted of an HP1100 thermostatted autosampler,
degasser, gradient pump, and thermostatted column com-
partment at 40 C. The LC column was a 150 · 2 mm i.d.
Agilent Zorbax XDB C18 (particle size 5 lm) with a
4 · 2 mm i.d. Agilent Zorbax XDB C8, 5-lm guard column.
The LC column effluent was pumped to a 2 position 6
port Valco valve (Valco Instrument Co., Houston, TX,
544 Accred Qual Assur (2007) 12:543–551
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USA) before it reached the triple quadrupole tandem mass
spectrometer Sciex API 3000 (Applied Biosystems, Foster
City, CA, USA) equipped with a TurboIonSpray ion
source. Data acquisition was controlled by Sciex Analyst1
software, version 1.4.1.
The statistic calculations were performed using the
package SPSS software, version 12.0.
Standard solutions
Individual stock standard solutions of the four nitrofuran
metabolites (AOZ, AMOZ, AHD and SEM) and the two
internal standards (AOZ-d4 and AMOZ-d5) were prepared
at 50.0 mg/L. All these stock standards solutions where
stored at the refrigerator and were considered stable for, at
least 6 months. Two composite standard working solutions
were prepared at 50.0 lg/L: one with all the nitrofurans
metabolites and other with the two internal standards. These
standard working solutions were stored at the refrigerator
and were shown to be stable for at least 1 month.
Samples
Meat samples from different animal species were mainly
collected by the Portuguese Veterinary Authority (Direcc¸a˜o
Geral de Veterina´ria-DGV) under the application of PRMP
and on sequestered farms where animals tested positive for
nitrofuran metabolites. After the declaration of an abnormal
situation in the country concerning food safety involving
the use of nitrofurans in food production animals, samples
were also collected and analyzed under an Action Plan and a
Contingency Plan, which were submitted to the European
Commission by Portuguese Authorities.
All the samples (weighing between 50 and 100 g) were
collected in dark plastic bags. The samples were trans-
ported in frozen or refrigerated conditions and, after
reception in the laboratory, were kept frozen (T = –16 to
–18 C) until analysis.
Sample preparation
A portion of 1.0 ± 0.05 g of minced and mixed muscle was
weighed into a 15-L screw top glass centrifuge tube. Then,
40 lL of composite standard working solution of internal
standards was added, homogenised, and let stand for about
15 min. Afterwards, 5 mL of a 0.2 mol/L hydrochloric
acid solution and 50 lL of a 0.1 mol/L o-NBA solution
in methanol were added and the tube was closed and sha-
ken by hand. The tube was then put in the Reax 2 agitator
in the incubator and hydrolysis was done overnight at
T = 37 ± 2 C. After cooling, 500 lL of a 0.3 mol/L tri-
sodium phosphate dodecahydrate solution was added to the
sample and the pH was adjusted to 7 ± 0.5 with a 2 mol/L
sodium hydroxide solution. Then, 4 mL of ethyl acetate
were added to the sample and the tube was shaken in the
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Reax 2 agitator for 20 min. The sample was centrifuged at
1,200 g for 10 min and the organic layer was transferred to
a 20-L centrifuge tube. The previous step was repeated and
the two organic layers were mixed and evaporated to
dryness at T = 45 C under a nitrogen stream. The dry
residue was dissolved in 500 lL of 10:90 (v:v) acetoni-
trile:water with 0.1% of acetic acid solution, vortexed for
20 s, and transferred to an autosampler LC amber vial
through a PVDF 0.45 lm filter.
For each batch of unknown samples, two blank meat
samples (one as blank control and the other spiked with
composite standard working solution of analytes in order to
obtain a concentration of 2 lg/kg as spiked standard mix-
ture sample) and a reagent blank sample were included.
Liquid chromatography-tandem mass spectrometry
(LC-MS/MS)
Sample was injected in the LC system with a flow rate of
450 lL/min. The mobile phase was composed of two solu-
tions: A (1.0 · 10–3 V acetic acid in water) and B
[acetonitrile:solution A (90:10 V/V)]. Mobile-phase linear
gradient program used was: 0–1 min 10% B, 1–14 min from
10 to 45% B, 14–16 min from 45 to 90% B, 18–19 min from
90 to 10% B, and 19–22 min 10% B. The injection volume
was 60 lL; and between injections, the needle was rinsed
with a solution of water/acetonitrile 1:1 (V/V).
The entire LC flow was directed into the MS detector
between 5 and 12 min by means the Valco valve. A split
ratio of about 1:2 was used. The mass spectrometer was
operated in positive electrospray ionisation mode (ESI+)
using the TurboIonSpray source. Nitrogen was used for
curtain, collision, heater, and nebulizer gas at flow rates of
10, 5, 8, and 6 L/min, respectively. The ion source block
temperature was set to T = 450 C, and the electrospray
capillary voltage to 5.0 kV. Data acquisition was per-
formed in the multiple reaction monitoring (MRM) mode.
As the identification of banned substances requires four
identification points, according to Commission Decision
2002/657/EC [18], fulfilment criteria were obtained with
one precursor ion and two product ions, two transition
reactions were monitoring for each nitrofuran metabolite as
their nitrophenyl derivative. For each deuterated internal
standard, only one transition was controlled. These transi-
tions and their corresponding collision energies are shown
in Table 1.
Residue determination
For screening and confirmation purposes, nitrofuran
metabolites, as their nitrophenyl derivatives, were detected
using the most abundant transition of the target analytes
(Table 1). Criteria used for detection was the presence of a
signal of the controlled transition with a relative retention
better than 2.5% when compared to analytes present on the
spiked standard mixture sample. When a representative
signal of analyte was observed, the second transition was
searched at the same relative retention time. When present,
the ion ratio of the two transitions was checked and com-
pared to the one obtained for the same analyte in the spiked
standard mixture sample. When ion ratio was identical,
after applying recommended tolerances of the Commission
Decision 2002/657/EC [18], a positive detection is
assumed.
For quantification, calibration curves at five concentra-
tions levels were prepared by spiking blank meat samples
with composite standard working solution of analytes
(AOZ, AMOZ, AHD, and SEM) at 0.0 (blank sample), 0.5,
1.0, 2.0, and 5 lg/kg. These fortified calibration samples
and the known positive samples were prepared using the
above described procedure of extraction. Calibration curve
samples were injected before and after known positive
samples, and both data were used to quantitative evalua-
tion. Analyte identification was re-checked following the
same criteria described above.
For AMOZ identification and quantification, internal
standard AMOZ-d5 was used, and for AHD, SEM and
AOZ, AOZ-d4 was utilized. A typical chromatogram is
shown in Fig. 2.
Results and discussion
Method validation
For method validation specificity, linearity, precision
(repeatability and within-laboratory reproducibility), accu-
racy, decision limit (CCa) and detection capability (CCb)
were determined according to Commission Decision 2002/
657/EC [18].
Specificity could be demonstrated by analysing 20 blank
meat samples before and after spiking at a concentration
Table 1 Ion transitions and corresponding collision energies used for
nitrofuran metabolites detection (base peak bolded)
Compound as their
nitrophenyl derivatives
Percursor
ion (m/z)
Product
ions (m/z)
Collission
energy (eV)
AOZ 236 104; 134 31, 21
AMOZ 335 262; 291 25, 17
AHD 249 134; 178 19, 23
SEM 209 166; 192 15, 17
AOZ-d4 (ISTD) 240 134 21
AMOZ-d5 (ISTD) 340 296 19
546 Accred Qual Assur (2007) 12:543–551
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level of 1.0 lg/kg. No interfering peaks of eligible size
were observed at the retention time windows for the
nitrofuran metabolites for the two MRM monitoring tran-
sitions of interest for each analyte.
For linearity, accuracy, precision and analytical limits,
calibration curves of AOZ, AMOZ, AHD, and SEM were
prepared using blank meat samples spiked at 0.0, 0.5, 1.0,
2.0, and 5.0 lg/kg and submitted to the extraction proce-
dure described above. For each calibration level, six
samples were prepared and analysed every day for 3 days.
Additionally one standard calibration curve without matrix
with the same calibrations levels was prepared and analy-
sed for each day.
Linearity of the chromatographic response was tested
with five calibration points in the concentration range of
0.5–5.0 lg/kg. The regression coefficients (r2) for the
calibration curves used in the method validation study were
‡0.993 (Table 2).
The accuracy in terms of recovery of the method was
measured at 0.5, 1.0, and 2.0 lg/kg for each nitrofuran
metabolite and from the most intense transition. The
accuracy determined in the three separate assays was
between 78 and 103% (Table 3).
The precision in terms of repeatability and intra-labo-
ratorial reproducibility was evaluated in particular the
within and between days variation, by calculating the
coefficient of variation (CV%) of the mean concentrations
results obtained from each analyte at 0.5, 1.0, and 2.0 lg/kg
levels of concentration in the 3 days. The values obtained
and shown in Table 3 for the 1.0 lg/kg level were lower
than 15% for any of the tested concentrations. Accordingly
with Commission Decision 2002/657/EC, coefficient of
variation for repeated analysis of spiked or incurred
material should not exceed the level obtained after the
application of the Horwitz equation, but this equation for
mass fractions lower than 100 lg/kg gave unacceptable
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Fig. 2 LC-MS/MS
chromatograms of a blank and
b spiked tissue sample at the
1 lg/kg level for AHD, AMOZ,
AOZ and SEM (NP nitrophenyl
derivatives)
Table 2 Calibration curve parameters obtained in spiked blank meat
samples
Analyte as their
nitrophenyl derivative
r2 Mean
slope
Mean
intercept
AOZ [0.995 1.532 0.160
AMOZ [0.996 1.856 0.138
AHD [0.996 0.864 0.198
SEM [0.993 1.337 0.209
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high values. As a guideline, a value as low as possible
should be reached. It was accepted that values lower than
23% are fit for the purposed.
Decision limit (CCa) and detection capability (CCb)
were calculated as stated by Commission Decision 2002/
657/EC [18] and by ISO 11843 [19]. For CCa, with
a = 1%, the calculation was performed with the application
of the following formula:
CCa ¼ b þ 2:33SDb
wherein b is the concentration of the intercept of the
regression line and SDb is the standard deviation from
regression line. The CCb at b = 5%, was then calculated as:
CCb ¼ CCaþ 1:64SDCCa
wherein SDCCa is the standard deviation at CCa
concentration.
As the minimum required performance limit (MRPL)
for nitrofurans was set at 1 lg/kg, the values obtained, and
summarized in Table 3, were shown to be appropriate.
Furaltadone residues
The analysis of nitrofurans in biological samples under
PRMP in 2002 was achieved using two distinguished ana-
lytical procedures. The samples collected between the
beginning of the year until September (n = 57), from vari-
ous species such as broilers, turkeys, quails, rabbits, bovine,
and swine, were submitted to nitrofuran detection by high
performance thin layer chromatography (HPTLC) or
HPLC-UV/VIS, using the parent compounds as target
analytes. All analyzed samples were shown to be compliant.
The remaining samples of the PRMP, collected after
September from the same species, were analyzed by the
LC-MS/MS method described above and introduced for the
routine detection and quantification of nitrofuran metabo-
lites as their nitrophenyl derivatives. From the 226
analyzed meat samples, 78 were demonstrated to be non-
compliant for furaltadone metabolite (AMOZ concentration
[1 lg/kg), of which 61 were from broiler, 11 from turkey,
5 from quail, and 1 from pig species.
The majority of the samples had presented low AMOZ
concentrations, reaching average values of 5.4 lg/kg
(n = 60) in broilers, 5.8 lg/kg (n = 5) in quails and 1.9 lg/
kg (n = 7) in turkeys. A more restricted number of samples
revealed much higher concentrations of furaltadone
metabolite such as in one broiler sample with a concen-
tration of 63 lg/kg, and in four turkeys with 943, 141, 138,
and 137 lg/kg residue levels. Non-compliant samples
involved 46 animal farms, namely broilers (n = 36), tur-
keys (n = 5), quails (n = 4), and pigs (n = 1).
The huge number of non-compliant results obtained led
the Portuguese authorities to recognize the existence of an
abnormal situation for national food safety and the corre-
sponding actions were taken.
The farms with non-compliant results were placed under
official control and subjected to a more stringent check for
nitrofuran residues. Meat, feeds, and drinking-water sam-
ples were collected and analyzed. A vast set of measures
was then introduced, in a special Action Plan presented by
Portuguese authorities to the European Commission and
approved on 9th May 2003. The application of these
measures had involved, among other things, collecting
biological samples, feed and drinking water samples cov-
ering all existent broilers, layer hens, turkeys, quails, and
ducks farms in the country. The Action Plan also includes
the control of swine, rabbits, and fish farms, but had a low
number of collected samples.
Data obtained from the analysis performed during the
first half of 2003 under the application of the above-men-
tioned measures, are presented in Table 4. All non-
compliant samples showed the presence of the furaltadone
metabolite, except one, where SEM was detected.
Data referring to non-complaints samples with AMOZ
concentration greater than 1 lg/kg were presented in
Table 5.
From the comparison of the mean, 5% trimmed mean,
and median obtained, for AMOZ concentration, unmatched
values were clear in the case of broilers and turkeys, due to
the existence of some mild and extreme outliers (Fig. 3).
To evaluate these outliers, broilers non-complaints
samples were divided into three groups in ascendant con-
centration, who where converted into ranks and submitted
to ANOVA test with multiple comparison. It was possible
Table 3 Performance
characteristics of the method
Analyte as their
nitrophenyl
derivative
CCa
(lg/kg)
CCb
(lg/kg)
Accuracy
at 1 lg/kg (%)
Repeatability
at 1 lg/kg (% CV)
Reproducibility
at 1 lg/kg (% CV)
AOZ 0.29 0.34 103 4.8 9.9
AMOZ 0.20 0.32 89 6.9 10.2
AHD 0.45 0.88 92 8.5 12.6
SEM 0.15 0.46 83 12.6 14.3
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to observe that the mean value of the three groups were
significantly different (p \ 0.000). Identical observations
were made from turkeys’ obtained data. The correspondent
boxplots are shown in Figs. 4 and 5.
These three concentration groups for broilers and tur-
keys, being statisticaly distinct, probably represent
different conditions of animal exposure to furaltadone.
According to the observations of Zuidema et al. [9],
the concentrations of AMOZ detected in muscle collected
from broilers that were fed a medicated feed (202 mg/kg
of furaltadone) were 1,000 lg/kg for animals slaughtered
1 day after stopping the compound’s administration and
diminished to 100 and 60 lg/kg in those animals
slaughtered 7–21 days after cessation of medication.
Previously, depletion studies of furaltadone metabolite in
porcine have shown very similar behaviour [2].
According to these data, the use of furaltadone thera-
peutic doses leads to the occurrence of high levels of
AMOZ in edible tissues. In line with these observations,
it was possible that broilers and turkeys that were shown
to have higher concentrations of furaltadone metabolite
in analysed tissues were probably fed with medicated
feed. The middle concentration ranges defined by statistic
evaluation from non-compliant samples of broilers and
turkeys were difficult to characterize, but suspension of
the administration of therapeutic concentrations of the
compound, some time before slaughtered, could be one
of the reasons, but, the great majority of the non-com-
plaint samples during the nitrofuran crisis showed
concentration levels lower than 8.4 lg/kg, with a median
value of 2.9 lg/kg in the case of broilers, and lower than
15 lg/kg, with a median value of 3.5 lg/kg, in the case
of turkeys (Table 5, Fig. 4).
This situation was also observed by O’Keeffe et al. [20]
in pork meat in a retail survey realized under the Food-
BRAND project undertaken across 15 European countries
in 2002. From the 12 positive samples, ten were purchased
in Portugal and contained AMOZ with concentrations
ranging from 0.2 to 0.6 lg/kg.
According to McCracken et al. [21], low levels of
administered furazolidone, nitrofurazone, nitrofurantoin or
furaltadone could be the origin of very low tissue-bound
nitrofuran metabolite concentrations in broilers’ edible
tissues; and these detected metabolites showed a linear
relation to the quantity of administered nitrofuran.
A frequent cause for these unwanted residues’ contam-
ination could be from an accidental feed contamination
by carry-over from medicated feed to subsequent unmed-
icated feed during the animal feed manufacturing process.
This possibility was proven through the administration of
Table 4 Analysed samples for
nitrofurans metabolites in the
first half of 2003
a AMOZ concentration
[1 lg/kg (w/1.0 · 10–9)
Animal/species Number of analysed
samples
Number of non-compliant
samples for AMOZa
Non-compliant sample
percentage by animal species
Broiler 693 260 37.5
Chicken 98 29 29.6
Turkey 158 81 51.3
Quail 40 21 52.5
Duck 50 7 14.0
Rabbit 50 1 2.0
Farm fish 52 18 34.6
Sparus aurata 20 1
Dicenthracus labrax 27 17
Scophtalmus sp. 1 0
Salmo truta 2 0
Salmo salar 2 0
Ovine 3 0 0
Swine 135 0 0
Bovine 25 0 0
Table 5 AMOZ concentration for non-compliant samples collected
at the first half of 2003
Animal
species
Number of
non-compliant
samples with
AMOZa
AMOZ concentration lg/kg
Mean value ± SD 5% trimmed
mean
Median
Broiler 244 5.1 ± 12.9 3.3 2.9
Chicken 29 2.3 ± 1.4 2.1 1.7
Turkey 81 46.1 ± 115.7 24.2 3.5
Quail 21 7.7 ± 5.8 7.3 5.7
Duck 7 1.4 ± 0.18 1.4 1.4
Rabbit 1 1.9
Farm fish 18 1.5 ± 0.3 1.4 1.4
a AMOZ concentration [1 lg/kg (w/1.0 · 10–9)
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furaltadone at sub-therapeutic doses to broilers, and the
observation that even a quantity of furaltadone of about
0.01% of the former therapeutic dose during 12 days could
cause detectable concentrations of AMOZ in edible tissues.
Raw material contaminated with nitrofurans’ parent com-
pounds or their protein bound metabolites; and exposure
of unmedicated animals to a contaminated environment
constitute known reasons for detectable low-level concen-
trations of tissue-bound nitrofuran metabolites [2, 19, 22].
From data obtained during the Portuguese nitrofuran
crisis it could be easily assumed that a high incidence of
furaltadone non-compliant results occurred, especially in
poultry meat, varying from 30 to 50% of analyzed samples.
A high level of AMOZ concentration, as referred to above,
could be connected to a deliberate illegal administration of
furaltadone by medicated feed or by drinking water.
However, in the great majority of the cases, observed
concentrations of AMOZ in edible tissues were very low,
and could have originated by accidental, unwanted or
unintended furaltadone administration.
After September 2003, until present, only one non-
complaint sample for nitrofuran metabolites was found in
samples collected on farm and on slaughterhouses as part
of the Portuguese plan for residues control.
Conclusions
The analytical methodology used until the middle of 2002
by the PRMP for detecting residues of nitrofuran com-
pounds by measuring the parent drugs was shown to
be inappropriate under EU requirements. It was clear that
their application couldn’t detect a generalized illicit or
inadvertent administration of furaltadone in intensive pro-
duction of poultry. The effective control of nitrofuran drugs
Fig. 3 Boxplot graphic for AMOZ concentrations of non-compliant
results obtain in the first half of 2003 for all species tested, showing
several mild (open circle) and extreme (asterisks) outliers for turkeys
and broilers
Fig. 4 Boxplot representing the three groups of non-compliant
samples in terms of AMOZ concentrations for broilers (mild (open
circle) and extreme (asterisks) outliers)
Fig. 5 Boxplot representing the three groups of non-compliant
samples in terms of AMOZ concentrations for turkeys (mild (open
circle) and extreme (asterisks) outliers)
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was achieved after the introduction of a highly specific and
sensitive LC-MS/MS method for long term detection of
residues of bound nitrofuran metabolites in edible tissues.
So, from data during the Portuguese nitrofuran crisis, it
could be easily seen that a high incidence of furaltadone
non-compliant results, especially in poultry meat, varied
from 30 to 50% of the analyzed samples. High levels of
AMOZ, as it was referred above, could be connected to a
deliberate illegal administration of furaltadone by medi-
cated feed or by drinking water. However, for the great
majority of the cases, the observed concentration of AMOZ
in edible tissues with values lower than 10 lg/kg could
have originated in accidental, unwanted, or unintended
contamination. Other than these conclusions, and taking
into account that the detection of nitrofuran metabolites in
food animal’s products was an offence to UE legislation, a
systematic procedure to evaluate nitrofuran in feeds and in
drinking water for animal production, namely poultry
production, was strongly recommended, in order to avoid
other similar outcomes that was caused by the so called
‘‘Portuguese nitrofuran crisis’’.
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